Zhuhai Rundu Pharmaceutical Co.,Ltd.(002923),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

002923 Zhuhai Rundu Pharmaceutical Co.,Ltd.

Closed 12-12 15:00:00

12.86

-0.08

-0.62%

High13.04	Low12.77	Vol3.05M
Open13.00	D1 Closing12.94	Amplitude2.09%
Mkt Cap4.31B	Tradable Cap3.32B	Total Shares335.00M
T/O39.20M	T/O Rate1.18%	Tradable Shares258.00M
P/B4.14	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"002923","market":"SZ","secType":"STK","nameCN":"Zhuhai Rundu Pharmaceutical Co.,Ltd.","latestPrice":12.86,"timestamp":1765523001000,"preClose":12.94,"halted":0,"volume":3048300,"delay":0,"changeRate":-0.0062,"floatShares":258000000,"shares":335000000,"eps":-0.1553,"marketStatus":"Closed","change":-0.08,"latestTime":"12-12 15:00:00","open":13,"high":13.04,"low":12.77,"amount":39204400,"amplitude":0.0209,"askPrice":12.87,"askSize":17,"bidPrice":12.86,"bidSize":126,"shortable":0,"etf":0,"ttmEps":-0.1553,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":12.94,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":14.23,"lowLimit":11.65,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":334893286,"isCdr":false,"pbRate":4.14,"roa":"--","roe":"--","epsLYR":0.12,"committee":0.722563,"marketValue":4307000000,"turnoverRate":0.0118,"status":1,"floatMarketCap":3319000000},"requestUrl":"/m/hq/s/002923","defaultTab":"news","newsList":[{"id":"1127544418","title":"Zhuhai Rundu Pharmaceutical (002923.SZ) Reports Net Loss of 54.6878 Million Yuan for First Three Quarters","url":"https://stock-news.laohu8.com/highlight/detail?id=1127544418","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127544418?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:56","pubTimestamp":1761836203,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ) released its third-quarter report for 2025. During the first three quarters, the company achieved operating revenue of 884 million yuan, a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2576080684","title":"Rundu Pharmaceutical Gets China Marketing Nod for Chest Pain Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2576080684","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576080684?lang=en_us&edition=fundamental","pubTime":"2025-10-17 17:12","pubTimestamp":1760692333,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical  obtained Chinese marketing approval for the isosorbide dinitrate active pharmaceutical ingredient for coronary heart disease, according to a Friday filing with the Shenzhen bourse.The drug is indicated for angina pectoris or chest pain, especially after a myocardial infarction or a heart attack, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"1117377518","title":"Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ): Approval Granted for Listing Application of Isosorbide Nitrate Raw Material Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1117377518","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117377518?lang=en_us&edition=fundamental","pubTime":"2025-10-16 16:34","pubTimestamp":1760603650,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ) recently announced that it has received the approval notification for the listing application of Isosorbide Nitrate from the National Medical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002923"],"gpt_icon":0},{"id":"1118995496","title":"Zhuhai Rundu Pharmaceutical Co.,Ltd. (002923.SZ) Receives Drug Registration Certificate for Valsartan Amlodipine Tablets (I)","url":"https://stock-news.laohu8.com/highlight/detail?id=1118995496","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118995496?lang=en_us&edition=fundamental","pubTime":"2025-09-29 15:57","pubTimestamp":1759132621,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical Co.,Ltd. (002923.SZ) announced that the company has recently received a Drug Registration Certificate issued by the National Medical Products Administration for Valsartan...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2570059070","title":"Zhuhai Rundu Pharmaceutical Gets China Supplementary Nod for Herpes Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2570059070","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570059070?lang=en_us&edition=fundamental","pubTime":"2025-09-26 17:00","pubTimestamp":1758877241,"startTime":"0","endTime":"0","summary":"Chinese authorities approved Zhuhai Rundu Pharmaceutical's  supplementary drug application for its valacyclovir hydrochloride tablets for herpes simplex, according to a Friday filing with the Shenzhen bourse.Herpes simplex causes painful blisters or sores and is usually transmitted through skin-to-skin contact, and is treatable but not curable, the World Health Organization said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"1161594841","title":"Zhuhai Rundu Pharmaceutical (002923.SZ) Receives Marketing Approval for Hydrochlorothiazide Chemical Raw Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1161594841","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161594841?lang=en_us&edition=fundamental","pubTime":"2025-08-19 17:20","pubTimestamp":1755595220,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical Co.,Ltd. (002923.SZ) announced that the company has recently received the \"Chemical Raw Drug Marketing Application Approval Notice\" for hydrochlorothiazide issued by the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2559668603","title":"Zhuhai Rundu Pharmaceutical Gets Marketing Approval for Osteoarthritis API","url":"https://stock-news.laohu8.com/highlight/detail?id=2559668603","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559668603?lang=en_us&edition=fundamental","pubTime":"2025-08-13 17:21","pubTimestamp":1755076895,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical  secured marketing approval from China's drug administrator for its glucosamine sulfate sodium chloride complex.The product is a chemical active pharmaceutical ingredient for osteoarthritis treatment, according to a Wednesday filing with the Shenzhen bourse.Shares of the pharmaceutical company closed 2% lower Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6100","002923","BK0239","BK6520","OTX.SI"],"gpt_icon":0},{"id":"2557360491","title":"Zhuhai Rundu Pharmaceutical Gets Approval for Muscle Relaxant","url":"https://stock-news.laohu8.com/highlight/detail?id=2557360491","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557360491?lang=en_us&edition=fundamental","pubTime":"2025-08-05 18:35","pubTimestamp":1754390114,"startTime":"0","endTime":"0","summary":"China's medical products administrator approved Zhuhai Rundu Pharmaceutical's  marketing application for cisatracurium besylate, according to a Tuesday filing with the Shenzhen bourse.The drug is indicated as a muscle relaxant, and could be used as an addition to anesthesia or as a sedative in intensive care, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"1152718103","title":"Zhuhai Rundu Pharmaceutical (002923.SZ) Receives Marketing Approval for Besylate Cisatracurium Chemical Raw Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1152718103","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152718103?lang=en_us&edition=fundamental","pubTime":"2025-08-04 16:00","pubTimestamp":1754294422,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical Co.,Ltd. (002923.SZ) announced that its wholly-owned subsidiary, Rundu Pharmaceutical (Jingmen) Co., Ltd. (referred to as \"Rundu Jingmen\"), has recently received the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2552434574","title":"BRIEF-Rundu Pharma's Shareholder To Unload Up To 3% Stake In Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2552434574","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552434574?lang=en_us&edition=fundamental","pubTime":"2025-07-20 15:53","pubTimestamp":1752998013,"startTime":"0","endTime":"0","summary":"BRIEF-Rundu Pharma's Shareholder To Unload Up To 3% Stake In CoJuly 20 (Reuters) - Zhuhai Rundu Pharmaceutical Co Ltd 002923.SZ:SAYS SHAREHOLDER PLANS TO UNLOAD UP TO 3% STAKE IN COSource textFurther company coverage: 002923.SZ (Reporting by Beijing Newsroom) ((Xiuhao.Chen@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250720:nL4N3TH01V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2548221350","title":"Rundu Pharmaceutical Gets Registration Certificate for Moxifloxacin Hydrochloride Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2548221350","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548221350?lang=en_us&edition=fundamental","pubTime":"2025-07-04 15:42","pubTimestamp":1751614928,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical  obtained a drug registration certificate from China's National Medical Products Administration for moxifloxacin hydrochloride tablets, according to a Shenzhen bourse disclosure on Friday.The pharmaceutical company will be able to produce the drug, which is used to treat acute bacterial sinusitis, acute exacerbation of chronic bronchitis, pneumonia, skin infections and other conditions.The company's shares closed over 1% lower.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2547706910","title":"Zhuhai Rundu Pharmaceutical Passes Brazilian GMP Certification for Four APIs","url":"https://stock-news.laohu8.com/highlight/detail?id=2547706910","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547706910?lang=en_us&edition=fundamental","pubTime":"2025-06-30 17:06","pubTimestamp":1751274396,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical  passed the Good Manufacturing Practice certification from Brazil's health regulator ANVISA for four active pharmaceutical ingredients.The APIs are candesartan cilexetil, sacubitril valsartan sodium, telmisartan and valsartan, according to a June 28 filing with the Shenzhen bourse.The certificates are valid through 2027.Shares of the pharmaceutical company closed less than 1% higher Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2546790442","title":"Zhuhai Rundu Pharmaceutical Passes US FDA On-Site Manufacturing Practice Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=2546790442","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546790442?lang=en_us&edition=fundamental","pubTime":"2025-06-27 16:33","pubTimestamp":1751013205,"startTime":"0","endTime":"0","summary":"Zhuhai Rundu Pharmaceutical  passed an on-site inspection from the US Food and Drug Administration related to nine active pharmaceutical ingredients, according to a Friday filing with the Shenzhen bourse.The inspection is related to current good manufacturing practices involving the production of candesartan cilexetil, olmesartan medoxomil, valsartan, irbesartan, valsartan sodium, sacubitril sodium, sacubitril-valsartan sodium, voriconazole, and hydroxychloroquine sulfate.The FDA inspection covered quality, production, equipment, laboratory control, and material management systems, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["002923","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-01-05","address":"广东省珠海市金湾区三灶镇机场北路6号","stockEarnings":[{"period":"1week","weight":-0.0647},{"period":"1month","weight":-0.0775},{"period":"3month","weight":-0.0761},{"period":"6month","weight":-0.1045},{"period":"1year","weight":0.1949},{"period":"ytd","weight":0.364}],"companyName":"珠海润都制药股份有限公司","boardCode":"AI0027","perCapita":"12801股","boardName":"医药制造业","registeredCapital":"33489万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　珠海润都制药股份有限公司的主营业务是化学药制剂、化学原料药、中间体的研发、生产和销售。公司的主要产品是制剂、原料药、医药中间体。公司是国家高新技术企业，研发中心先后被认定为国家级博士后科研工作站、国家企业技术中心、广东省企业技术中心、广东省缓控释微丸胶囊制剂工程研究中心，承担了国家十二五重大新药创制专项、国家火炬计划、国家高新技术产业化项目等科研课题。","serverTime":1765685713316,"listedPrice":17.01,"stockholders":"20160人(较上一季度减少2.77%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zhuhai Rundu Pharmaceutical Co.,Ltd.(002923),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zhuhai Rundu Pharmaceutical Co.,Ltd.(002923) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zhuhai Rundu Pharmaceutical Co.,Ltd.,002923,Zhuhai Rundu Pharmaceutical Co.,Ltd.股票,Zhuhai Rundu Pharmaceutical Co.,Ltd.股票老虎,Zhuhai Rundu Pharmaceutical Co.,Ltd.股票老虎国际,Zhuhai Rundu Pharmaceutical Co.,Ltd.行情,Zhuhai Rundu Pharmaceutical Co.,Ltd.股票行情,Zhuhai Rundu Pharmaceutical Co.,Ltd.股价,Zhuhai Rundu Pharmaceutical Co.,Ltd.股市,Zhuhai Rundu Pharmaceutical Co.,Ltd.股票价格,Zhuhai Rundu Pharmaceutical Co.,Ltd.股票交易,Zhuhai Rundu Pharmaceutical Co.,Ltd.股票购买,Zhuhai Rundu Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zhuhai Rundu Pharmaceutical Co.,Ltd.(002923),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zhuhai Rundu Pharmaceutical Co.,Ltd.(002923) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction